Question 1

Does Cresset Asset Management own PVLA stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Cresset Asset Management holds 11,629 shares of PVLA (Palvella Therapeutics), worth $1.8M.

Question 2

How many shares of PVLA does Cresset Asset Management own?

Accepted Answer

As of its Q2 2026 13F, Cresset Asset Management holds 11,629 shares of PVLA (Palvella Therapeutics).

Question 3

What is Cresset Asset Management's PVLA position worth?

Accepted Answer

As of its Q2 2026 13F, Cresset Asset Management's PVLA position is worth $1.8M.

Question 4

Is Cresset Asset Management buying or selling PVLA?

Accepted Answer

In Q2 2026, Cresset Asset Management reduced its PVLA position by 231 shares (-2.0%).

Question 5

When did Cresset Asset Management first buy PVLA?

Accepted Answer

Cresset Asset Management first reported PVLA in its Q4 2024 13F and has listed it in 7 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	11,629	-1.9%	$1.8M	0.0%	$152.82	0
2026-Q1	Increased	11,860	+3.8%	$1.5M	0.0%	$124.65	27
2025-Q4	Decreased	11,429	-34.4%	$1.2M	0.0%	$104.67	0
2025-Q3	Decreased	17,424	-16.7%	$1.1M	0.0%	$62.69	0
2025-Q2	Unchanged	20,911	0.0%	$471,334	0.0%	$22.54	0
2025-Q1	Unchanged	20,911	0.0%	$585,299	0.0%	$27.99	0
2024-Q4	New	20,911	—	$250,932	0.0%	$12.00	32